Literature DB >> 32100643

Public health concerns over gene-drive mosquitoes: will future use of gene-drive snails for schistosomiasis control gain increased level of community acceptance?

Damilare O Famakinde1.   

Abstract

With the advent of CRISPR (clustered regularly interspaced short palindromic repeat)-based gene drive, present genetic research in schistosomiasis vector control envisages the breeding and release of transgenic schistosome-resistant (TSR) snail vectors to curb the spread of the disease. Although this approach is still in its infancy, studies focussing on production of genetically modified (GM) mosquitoes (including gene-drive mosquitoes) are well advanced and set the pace for other transgenic vector research. Unfortunately, as with other GM mosquitoes, open field release of gene-drive mosquitoes is currently challenged in part by some concerns such as gene drive failure and increased transmission potential for other mosquito-borne diseases among others, which might have adverse effects on human well-being. Therefore, not only should we learn from the GM mosquito protocols, frameworks and guidelines but also appraise the applicability of its current hurdles to other transgenic vector systems, such as the TSR snail approach. Placing these issues in a coherent comparative perspective, I argue that although the use of TSR snails may face similar technical, democratic and diplomatic challenges, some of the concerns over gene-drive mosquitoes may not apply to gene-drive snails, proposing a theory that community consent will be no harder and possibly easier to obtain for TSR snails than the experience with GM mosquitoes. In the future, these observations may help public health practitioners and policy makers in effective communication with communities on issues regarding the use of TSR snails to interrupt schistosomiasis transmission, especially in sub-Saharan Africa.

Entities:  

Keywords:  Schistosomiasis; gene drive; genetically modified mosquitoes; public health; resistant snails; social acceptance; vector control

Mesh:

Year:  2020        PMID: 32100643      PMCID: PMC7170313          DOI: 10.1080/20477724.2020.1731667

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  64 in total

1.  Ethical, legal and social issues of genetically modifying insect vectors for public health.

Authors:  Darryl Macer
Journal:  Insect Biochem Mol Biol       Date:  2005-03-28       Impact factor: 4.714

2.  Genetic selection for tolerance to niclosamide and copper in Biomphalara glabrata (Mollusca: Pulmonata).

Authors:  J T Sullivan; T C Cheng; C C Chen
Journal:  Tropenmed Parasitol       Date:  1984-09

3.  Genetic diversity of the African malaria vector Anopheles gambiae.

Authors: 
Journal:  Nature       Date:  2017-11-29       Impact factor: 49.962

4.  Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.

Authors:  Thomas Crellen; Martin Walker; Poppy H L Lamberton; Narcis B Kabatereine; Edridah M Tukahebwa; James A Cotton; Joanne P Webster
Journal:  Clin Infect Dis       Date:  2016-07-28       Impact factor: 9.079

5.  Conservation demands safe gene drive.

Authors:  Kevin M Esvelt; Neil J Gemmell
Journal:  PLoS Biol       Date:  2017-11-16       Impact factor: 8.029

6.  A multistrain approach to studying the mechanisms underlying compatibility in the interaction between Biomphalaria glabrata and Schistosoma mansoni.

Authors:  Richard Galinier; Emmanuel Roger; Yves Moné; David Duval; Anaïs Portet; Silvain Pinaud; Cristian Chaparro; Christoph Grunau; Clémence Genthon; Emeric Dubois; Anne Rognon; Nathalie Arancibia; Bernard Dejean; André Théron; Benjamin Gourbal; Guillaume Mitta
Journal:  PLoS Negl Trop Dis       Date:  2017-03-02

7.  Engineered resistance to Zika virus in transgenic Aedes aegypti expressing a polycistronic cluster of synthetic small RNAs.

Authors:  Anna Buchman; Stephanie Gamez; Ming Li; Igor Antoshechkin; Hsing-Han Li; Hsin-Wei Wang; Chun-Hong Chen; Melissa J Klein; Jean-Bernard Duchemin; Prasad N Paradkar; Omar S Akbari
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-05       Impact factor: 11.205

8.  Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?

Authors:  Jaspreet Toor; Ramzi Alsallaq; James E Truscott; Hugo C Turner; Marleen Werkman; David Gurarie; Charles H King; Roy M Anderson
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

Review 9.  Genetically engineered mosquitoes, Zika and other arboviruses, community engagement, costs, and patents: Ethical issues.

Authors:  Zahra Meghani; Christophe Boëte
Journal:  PLoS Negl Trop Dis       Date:  2018-07-26

Review 10.  Population modification of Anopheline species to control malaria transmission.

Authors:  Rebeca Carballar-Lejarazú; Anthony A James
Journal:  Pathog Glob Health       Date:  2018-02-01       Impact factor: 2.894

View more
  2 in total

1.  Demystifying the Risk Assessment Process for Laboratory-Based Experiments Utilizing Invasive Genetic Elements: It Is More Than Gene Drive.

Authors:  Zach N Adelman
Journal:  Appl Biosaf       Date:  2021-09-13

2.  Handling Ethics Dumping and Neo-Colonial Research: From the Laboratory to the Academic Literature.

Authors:  Jaime A Teixeira da Silva
Journal:  J Bioeth Inq       Date:  2022-06-22       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.